Situation

• A Chief Data Officer (CDO) at a top 10 global pharmaceutical company had a bold vision: to shift the organization’s mindset and operations from treating data as a technical asset to embracing it as a strategic asset.

• Despite having vast data resources, business stakeholders viewed the CDO office as an IT gatekeeper rather than a partner in innovation.

• The challenge was to redesign the operating model to unlock data’s full potential—especially in the context of accelerating AI adoption across clinical and commercial functions.

Action

• Partnered with the CDO to reimagine the data operating model, embedding analytics capabilities into core workflows and decision-making processes.

• Established cross-functional data pods to support business units with tailored insights

• Integrated AI-powered analytics platforms to enable predictive modeling and real-time decision support

• Created governance frameworks that balanced innovation with compliance, communication, and stakeholder alignment

• Deeply examined use case scenarios in simulation, patient cohort identification, and market forecasting

Our Strategic Impact

• The redesigned model empowered business teams to treat data as fuel for strategic decisions rather than a technical hurdle.

• Analytical tools run by the CDO office helped answer high-priority questions faster and with greater precision.

• The perception of the CDO office shifted dramatically—from a bottleneck to an enabler for stakeholders on the business side.